InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the complete record of transactions filed by Winningham Rick E, Chairman & CEO. Insider active across 2 companies, notably Theravance Biopharma, Inc.. In total, 13 filings have been recorded. Total volume traded: €327k. The latest transaction was disclosed on 20 May 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is free.
Declarations13 total
€91,08511,025 shares@ €8.26170.011% mcap8.6% of flow
Ordinary Shares
SEC:0001415889-22-005633:0·
0170,000 shares0
Ordinary Shares
SEC:0001415889-22-002078:0·
€192,00622,710 shares@ €8.45470.023% mcap18.2% of flow
Ordinary Shares
SEC:0001415889-22-001703:0·
€83,86211,404 shares@ €7.35370.010% mcap7.9% of flow
Ordinary Shares
SEC:0001415889-21-005463:0·
€83,86211,404 shares@ €7.35370.010% mcap7.9% of flow
Ordinary Shares
SEC:0001415889-21-005463·
€137,22011,404 shares@ €12.03260.016% mcap35.4% of flow
Ordinary Shares
SEC:0001179110-21-008404·
€137,22011,404 shares@ €12.03260.016% mcap13.0% of flow
Ordinary Shares
SEC:0001179110-21-008404:0·
€163,2651,306 shares@ €125.01140.0011% mcap100.0% of flow
Ordinary Shares
SEC:0001765581-21-000112·
€163,2651,306 shares@ €125.01140.0011% mcap50.0% of flow
Ordinary Shares
SEC:0001765581-21-000112:0·
02,246 shares0
Ordinary Shares
SEC:0001765581-21-000087·
02,246 shares0
Ordinary Shares
SEC:0001765581-21-000087:0·
€166,04111,404 shares@ €14.55990.020% mcap42.9% of flow
Ordinary Shares
SEC:0001179110-21-005852·
€166,04111,404 shares@ €14.55990.020% mcap15.7% of flow
Ordinary Shares
SEC:0001179110-21-005852:0·
13 of 13 declarations
About Winningham Rick E
Rick E. Winningham is the Chief Executive Officer of Theravance Biopharma, Inc. and Jazz Pharmaceuticals plc. With extensive experience in the pharmaceutical industry, he leads the development and marketing strategies for the products of both companies.
